Moreover, in Alzheimer’s disease, and Parkinson’s disease, Seipin expression decreased, accompanied by lipid dysregulation and myelin deficits [33–36], All those evidences suggest Seipin, as a vital lipid metabolism mediator, play essential role in myelin plasticity. This evidence concerns the gene BSCL2 and early-onset autosomal dominant Alzheimer disease.